Abstract Purpose of Review Ankylosing spondylitis (AS) was historically seen as a
predominantly male disease. However, more recent data showed a more homogenous sex …

Mounting evidence reveals evident sex differences in physiology, disease presentation and
response to medication in axial SpA (axSpA). Unfortunately these data are often neglected …

Objectives To update the Assessment of SpondyloArthritis international Society (ASAS)-
EULAR recommendations for the management of axial spondyloarthritis (axSpA). Methods …

A taskforce comprised of an expert group of 21 rheumatologists, radiologists and
methodologists from 11 countries developed evidence-based recommendations on the use …

Objectives To analyse the impact of tumour necrosis factor inhibitors (TNFis) on spinal
radiographic progression in ankylosing spondylitis (AS). Methods Patients with AS in the …

Objective To study the effect of tumor necrosis factor α (TNFα) inhibitors on progressive
spinal damage in patients with ankylosing spondylitis (AS). Methods All AS patients meeting …

Objectives To analyse the long-term relationship between disease activity and radiographic
damage in the spine in patients with ankylosing spondylitis (AS). Methods Patients from the …

Objective To assess prospectively the rates and to explore predictors of spinal radiographic
progression over 2 years in a cohort of patients with early axial spondylarthritis (SpA) …

Objective Compare the radiographic progression of ankylosing spondylitis (AS) patients
treated with infliximab (INF) versus historical controls (Herne cohort, HC) never treated with …

In ankylosing spondylitis (AS), structural damage that occurs as a result of syndesmophyte
formation and ankylosis of the vertebral column is irreversible. Structural damage is currently …